Burley Oak founder reflects on five years of craft beer and helping make Berlin cool
The Baltimore Sun

Multiple sclerosis drug approved FDA

Multiple sclerosis patients, who often suffer mobility impairments as the disease progresses, now have a new medication, Tecfidera, that may slow the march of the auto-immune disease.
Glenn Koenig / Los Angeles Times
Copyright © 2016, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad
77°